SCHEMBL1661593

SCHEMBL1661593

NC(C1=CC[CH]C(F)=C1)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1663575 0.78
SCHEMBL296872 0.58 IDO1 (0.44)
SCHEMBL14305986 0.58 IDO1 (0.44)
SCHEMBL2547326 0.57
SCHEMBL1662055 0.57 TAAR1 (0.31)
Hydrochloric Acid SCHEMBL25187772 0.57 IDO1 (0.46)
Hydrochloric Acid SCHEMBL22713509 0.57 IDO1 (0.46)
Hydrochloric Acid SCHEMBL22713511 0.57 IDO1 (0.46)
SCHEMBL2551842 0.57
SCHEMBL20531764 0.52 CES2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2011524906-A 2011-09-08 JP claimed
EP-2306994-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF Amgen, Inc (US) 2011-04-13 EP claimed
WO-2009154775-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF AMGEN INC. (US) 2009-12-23 WO claimed
EP-2306994-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF Amgen, Inc (US) 2011-04-13 EP disclosed
WO-2009154775-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF AMGEN INC. (US) 2009-12-23 WO disclosed